Results 181 to 190 of about 15,163 (213)

Essential Thrombocythemia

Seminars in Hematology, 2005
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philadelphia (Ph) chromosome-negative myeloproliferative disorders (MPDs) has recently been achieved. Unfortunately, the diagnosis of ET still relies on a set of exclusion criteria developed years ago, as recent advances have yet to ...
Guido, Finazzi, Claire, Harrison
openaire   +4 more sources

Management of Essential Thrombocythemia

Critical Reviews in Oncology/Hematology, 1999
3. Risk stratification of patients with ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.1. Bleeding and thrombosis in ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.2. Risk factors for major bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259 3.3. Risk factors for thrombosis. .
T, Barbui, G, Finazzi
openaire   +2 more sources

Essential thrombocythaemia

Best Practice & Research Clinical Haematology, 2003
Essential thrombocythaemia is a myeloproliferative disorder that results from the transformation of a multipotent haematopoietic progenitor. Its diagnosis can be challenging and its optimal management has been controversial, largely because of a virtual absence of randomised trials.
Claire N, Harrison, Anthony R, Green
openaire   +3 more sources

Essential Thrombocythemia in Childhood

Seminars in Thrombosis and Hemostasis, 1997
In addition to the criteria of the Polycythemia Vera Study Group, positive markers for essential thrombocythemia (ET) include spontaneous BFU-E, splenomegaly, and megakaryocyte morphology in bone marrow smears and biopsy material. The hematologic features of 11 reported cases of ET in childhood showed platelet counts in excess of 1000 x 10(9)/L in all,
J J, Michiels, P J, Van Genderen
openaire   +2 more sources

Essential thrombocythemia and pregnancy

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
Essential thrombocythaemia (ET) is an acquired myeloproliferative neoplasm, characterised by persistent thrombocytosis and a tendency for either thrombosis or haemorrhage. Among myeloproliferative neoplasms, ET is the most prevalent in young women, which constitute a special group due to their childbearing potential.
Valera, Marie-Cécile, Parant, Olivier, Vayssiere, Christophe, Arnal, Jean-François, Payrastre, Bernard   +4 more
openaire   +3 more sources

Pharmacotherapy of essential thrombocythemia

Expert Opinion on Pharmacotherapy, 2008
The natural history of essential thrombocythemia is characterized by an increased incidence of thrombotic and hemorrhagic events and, in the long-term, a tendency for disease transformation to myelofibrosis or acute leukemia. Advanced age and a prior history of thrombosis are the major predictors of thrombotic complications.The aim of this study was to
Naseema, Gangat, Ayalew, Tefferi
openaire   +2 more sources

Essential Thrombocythemia in an Infant

Journal of Pediatric Hematology/Oncology, 1996
To report the unusual occurrence of essential thrombocythemia (ET) in a 5-month-old infant.The child was referred by her pediatrician for a high platelet count detected on routine blood testing. The child was asymptomatic except for failure to thrive. Diagnostic tests to rule out secondary causes of thrombocytosis as well as myeloproliferative syndrome
G, Kapoor, H, Correa, L C, Yu
openaire   +2 more sources

Interferon-alpha in the Treatment of Essential Thrombocythemia

Leukemia and Lymphoma, 1996
E Lengfelder, Martin Grieshammer
exaly  

Acute coronary disease in essential thrombocythemia and polycythemia vera

Journal of Internal Medicine, 1998
M L Randi, P Zerbinati, V Rinaldi
exaly  

Treatment of essential thrombocythemia

Blood, 2016
openaire   +2 more sources